Interleukin-8 and tumor necrosis factor-alpha are increased in minimal change disease but do not alter albumin permeability

American Journal of Nephrology

Volumn 23, Issue 4, 2003, Pages 260-266

  Cho, Min Hyun ^a   Lee, Hwan Seok ^a   Choe, Byung Ho ^a   Kwon, Soon Hak ^a   Chung, Ki Young ^b   Koo, Ja Hoon ^a   Ko, Cheol Woo ^a  

^a Kyungpook National University Hospital   (South Korea)

^b Biomedical Research Institute   (South Korea)

Author keywords

Albumin permeability; Glomerular epithelial cell; Interleukin 8; Minimal change nephrotic syndrome; Tumor necrosis factor alpha

Indexed keywords

ALBUMIN; HEPARAN SULFATE; INTERLEUKIN 8; PROTEOHEPARAN SULFATE; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ANIMAL CELL; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION REGULATION; GLOMERULUS BASEMENT MEMBRANE; GLOMERULUS EPITHELIUM; HUMAN; KIDNEY BIOPSY; MALE; MEMBRANE PERMEABILITY; MINIMAL CHANGE GLOMERULONEPHRITIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN URINE LEVEL; RAT; RELAPSE; REMISSION; SYNTHESIS;

ADOLESCENT; ALBUMINS; BASEMENT MEMBRANE; CHILD; CHILD, PRESCHOOL; EPITHELIUM; FEMALE; HEPARAN SULFATE PROTEOGLYCANS; HEPARITIN SULFATE; HUMANS; INTERLEUKIN-8; KIDNEY GLOMERULUS; MALE; NEPHROSIS, LIPOID; PERMEABILITY; RECURRENCE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0042073060     PISSN: 02508095     EISSN: None     Source Type: Journal    
DOI: 10.1159/000072065     Document Type: Article

References (45)

1. A Report of the International Study of Kidney Disease in Children: Primary nephrotic syndrome in children: Identification of patients with minimal change nephrotic syndrome from initial response to prednisone. J Pediatr 1981;98:561-564.
2. Sewell RF, Short CD: Minimal-change nephropathy: How does the immune system affect the glomerulus? Nephrol Dial Transplant 1993;8:108-112.
3. Koyama A, Fujisaki M, Kobayashi M, Igarashi M, Narita M: A glomerular permeability factor produced by human T cell hybridomas. Kidney Int 1991;40:453-460.
4. Guasch A, Deen WM, Myers BD: Charge selectivity of the glomerular filtration barrier in healthy and nephrotic humans. J Clin Invest 1993;92:2274-2282.
5. Guasch A, Hashimoto H, Sibley RK, Deen WM, Myers BD: Glomerular dysfunction in nephrotic humans with minimal changes or focal glomerulosclerosis. Am J Physiol 1991;260:F728-737.
6. Wilkinson AH, Gillespie C, Hartley B, Gwyn Williams D: Increase in proteinuria and reduction in number of anionic sites in the glomeru-lar basement membrane in rabbits by infusion of human nephrotic plasma in vivo. Clin Sci (Colch) 1989;77:43-48.
7. Zimmerman SW: Increased urinary protein excretion in the rat produced by serum from a patient with recurrent focal glomerular sclerosis after renal transplantation. Clin Nephrol 1984;22:32-38.
8. Boulton Jones JM, Tulloch I, Dore B, McLay A: Changes in the glomerular capillary wall induced by lymphocyte products and serum of nephrotic patients. Clin Nephrol 1983;20:72-77.
9. Yoshizawa N, Kusumi Y, Matsumoto K, Oshima S, Takeuchi A, Kawamura O, Kubota T, Kondo S, Niwa H: Studies of a glomerular permeability factor in patients with minimal-change nephrotic syndrome. Nephron 1989;51: 370-376.
10. Maruyama K, Tomizawa S, Shimabukuro N, Fukuda T, Johshita T, Kuroume T: Effect of supernatants derived from T lymphocyte culture in minimal change nephrotic syndrome on rat kidney capillaries. Nephron 1989;51:73-76.
11. Tanaka R, Yoshikawa N, Nakamura H, Ito H: Infusion of peripheral blood mononuclear cell products from nephrotic children increases albuminuria in rats. Nephron 1992;60:35-41.
12. Koyama A, Fujisaki M, Kobayashi M, Igarashi M, Narita M: A glomerular permeability factor produced by human T cell hybridomas. Kidney Int 1991;40:453-460.
13. Cheung PK, Dejkhuis FWJ, Bakker WW: The endothelial cell as potential target for a human vasoactive plasma factor associated with minimal change nephrotic syndrome (abstract). J Am Soc Nephrol 1995;6:656.
14. Garin EH, Blanchard DK, Matsushima K, Djeu JY: IL-8 production by peripheral blood mononuclear cells in nephrotic patients. Kidney Int 1994;45:1311-1317.
15. Neuhaus TJ, Wadhwa M, Callard R, Barratt HTM: Increased IL2, IL4 and interferon-gamma (IFN-γ) in steroid-sensitive nephrotic syndrome. Clin Exp Immunol 1995;100:475-479.
16. Bustos C, Gonzalez E, Muley R, Alonso JL, Egido J: Increase of tumor necrosis factor alpha synthesis and gene expression in peripheral blood mononuclear cells of children with idiopathic nephrotic syndrome. Eur J Clin Invest 1994;24:799-805.
17. Yoshimura TR, Matsushima K, Oppenheim JJ, Leonard EJ: Neutrophil chemotactic factor produced by lipopolysaccharide (LPS)-stimulated human blood mononuclear leukocytes: Partial characterization and separation from interleukin 1(IL-1). J Immunol 1987;139:788-793.
18. Matsumoto K: IL-8 release from cultured peripheral blood monocytes of patients with glomerulonephritis. Clin Exp Immunol 1995;99: 106-111.
19. Garin EH, West L, Wang Z: Effect of interleukin 8 on glomerular sulfated compounds and albuminuria. Pediatr Nephrol 1997;11:274-279.
20. Wardle EN: Cytokine growth factors and glomerulonephritis. Nephron 1991;57:257-261.
21. Noble B, Ren K, Taverne J, Dipirro J, Van Liew J, Dijkstra C, Janossy G, Poulter LW: Mononuclear cells in glomeruli and cytokines in urine reflect the severity of experimental proliferative immune complex glomerulonephritis. Clin Exp Immunol 1990;80:281-287.
22. Wardle EN: Cell biology and glomerulonephritis. Nephron 1991;59:529-532.
23. Tipping PG, Leong TR, Holdsworth ST: Tumor necrosis factor production by macrophages in anti-glomerular basement membrane glomerulonephritis in rabbits. Lab Invest 1991; 65:272-279.
24. Kreisberg JL, Hoover RL, Karnovsky MJ: Isolation and characterization of rat glomerular cells in vitro. Kidney Int 1978;14:21-30.
25. Hammes M, Singh A: Effect of polycations on permeability of glomerular epithelial cell monolayers to albumin. J Lab Clin Med 1994; 123:437-446.
26. Singh AK, Mo W, Dunea G, Arruda JAL: Effect of glycated proteins on the matrix of glomerular epithelial cells. J Am Soc Nephrol 1998;9:802-810.
27. Pegoraro AA, Singh AK, Arruda JAL, Dunea G, Bakir AA: A simple method to detect an albumin permeability factor in the idiopathic nephrotic syndrome. Kidney Int 2000;58:1342-1345.
28. Chomczynski P, Sacchi N: Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-159.
29. Noonan DM, Fulle A, Valente P, Cai S, Horigan E, Sasaki M, Yamada Y, Hassell JR: The complete sequence of perlecan, a basement membrane heparan sulfate proteoglycan, reveals extensive similarity to laminin A chain, low density lipoprotein receptor and the neural cell adhesion molecule. J Biol Chem 1991;266:22939-22947.
30. Kallunki P, Tryggvason K: Human basement membrane heparan sulfate proteoglycan core protein: A 467 kD protein containing multiple domains resembling elements of the low density lipoprotein receptor, laminin, neural cell adhesion molecule and epidermal growth factor. J Cell Biol 1992;116:559-571.
31. Ledbetter SR, Tyree B, Hassell JR, Horigan EA: Identification of precursor protein to basement membrane heparan sulfate proteoglycan. J Biol Chem 1985;260:8106-8113.
32. Cheung PK, Klok PA, Baller JF, Bakker WW: Induction of experimental proteinuria in vivo following infusion of human plasma hemopexin. Kidney Int 2000;57:1512-1520.
33. Cheung PK, Stulp B, Immenschuh S, Borghuis T, Baller JF, Bakker WW: Is 100KF an isoform of hemopexin? Immunochemical characterization of the vasoactive plasma factor 100KF. J Am Soc Nephrol 1999;10:1700-1708.
34. Garin EH: Effect of lipoid nephrosis cytokine on glomerular sulfated compounds and albuminuria. Pediatr Nephrol 1995;9:587-593.
35. Nakanishi I, Montabarrick A, Okada N, Kita-mura E, Hayashi A, Syouji T, Namiki M, Ishi-bashi M, Zaid D, Tsubakihara Y: Interleukin-8 in chronic renal failure and dialysis patients. Nephrol Dial Transplant 1994;9:1435-1442.
36. Wada T, Yokoyama H, Tomosugi N, Hisada Y, Ohta S, Naito T, Kobayashi K, Mukaida N, Matsushima K: Detection of urinary interleu-kin-8 in glomerular diseases.Kidney Int 1994;46:455-460.
37. Ko CW, Bhandari B, Yee J, Terhune WC, Maldonado R, Kasinath BS: Cyclic AMP regulates basement membrane heparan sulfate proteoglycan, perlecan, metabolism in rat glomerular epithelial cells. Mol Cell Biochem 1996;162: 65-73.
38. Garin EH, West L, Blanchard K, Matsushima K, Djeu JY: Effect of sulfate uptake by the glomerular basement membrane. Nephron 1995; 71:442-447.
39. Narita J, Morioka T, Yoshida K: Monocytes secrete factors that regulate glycosaminoglycan synthesis by mesangial cells in vitro (abstract). Kidney Int 1989;35:357.
40. Ko CW, Koo JH, Chang HJ, Kasinath BS: Permeability factor which was drawn from children with minimal change disease reversibly suppresses glomerular basement membrane heparan sulfate proteoglycan mRNA expression in rats glomerular epithelial cells (abstract). J Am Soc Nephrol 1999;10:106A.
41. Singh AK, Mo W, Dunea G, Arruda JAL: Effect of glycated proteins on the matrix of glo-merular epithelial cells. J Am Soc Nephrol 1998;9:902-910.
42. Raats CJI, van den Born J, Berden HM: Glomerular heparan sulfate alterations: Mechanisms and relevance for proteinuria. Kidney Int 400;57:385-400.
43. Suranyi MG, Guasch A, Hall BM, Myers BD: Elevated levels of tumor necrosis factor-alpha in the nephrotic syndrome in humans. Am J Kidney Dis 1993;21:251-259.
44. Nakamura T, Miller D, Ruoslahti E, Border WA: Production of extracellular matrix by glomerular epithelial cells is regulated by transforming growth factor-β1. Kidney Int 1992;41: 1213-1221.
45. Shewring L, Thomas GJ, Davies M: Proteoglycan synthesis is stimulated by TNF in rat mesangial cell in vitro (abstract). Clin Sci 1989; 76(suppl):20.